摘要:
A buffer circuit with slow output edges is described. Pulsed higher value currents are driven from one shot timing circuits to inject a pulse of current into the control gate of the buffer's output MOSFET to speed up the beginning of the turning on or the turning off of the output MOSFT. When the beginning and turning on and off is reached lower value current sources continue to drive the gate of the output MOSFET. In one embodiment, one shots are triggered from the rising and falling edges of the input signal. The effect of the higher value current pulses is to reduce the circuit delay through the buffer. Also, the pulse width can be designed as temperature sensitive, and supply voltage sensitive so as to maintain the buffer circuit delay as substantially constant as temperature, supply voltage and process variation occur.
摘要:
The present invention relates to trivalent, bispecific antibodies, methods for their production, pharmaceutical compositions containing the antibodies, and uses thereof.
摘要:
The current invention reports a promoter having the nucleic acid sequence of SEQ ID NO: 02, or SEQ ID NO: 03, or SEQ ID NO: 04, or SEQ ID NO: 06, which is a 5′ shortened SV40 promoter with reduced promoter strength especially useful for the limited expression of heterologous polypeptides or selectable markers.
摘要翻译:本发明报告了具有SEQ ID NO:02或SEQ ID NO:03或SEQ ID NO:04或SEQ ID NO:06的核酸序列的启动子,其是具有降低的启动子的5'缩短的SV40启动子 对于异源多肽或选择性标记的有限表达特别有用的强度。
摘要:
The present invention relates to bispecific, bivalent antibodies against human vascular endothelial growth factor (VEGF/VEGF-A) and against human angiopoietin-2 (ANG-2), methods for their production, pharmaceutical compositions containing said antibodies, and uses thereof.
摘要:
A computing system translates a world space position of a hand of a human target to a screen space position of a user interface and locks the hand to a handle of the user interface if world space parameters of the hand overcome a grab threshold of the handle. When the hand is locked to the handle, the computing system translates a world space position of the hand to a screen space handle position that is constrained along one or more interface guides. The hand is unlocked from the handle at a release position of the handle if world space parameters of the hand overcome a release threshold of the handle. The handle is retained at the release position after the hand is unlocked from the handle.
摘要:
A system and method are disclosed for tracking image and audio data over time to automatically identify a person based on a correlation of their voice with their body in a multi-user game or multimedia setting.
摘要:
Embodiments are disclosed that relate to the use of identity information to help avoid the occurrence of false positive speech recognition events in a speech recognition system. One embodiment provides a method comprising receiving speech recognition data comprising a recognized speech segment, acoustic locational data related to a location of origin of the recognized speech segment as determined via signals from the microphone array, and confidence data comprising a recognition confidence value, and also receiving image data comprising visual locational information related to a location of each person in an image. The acoustic locational data is compared to the visual locational data to determine whether the recognized speech segment originated from a person in the field of view of the image sensor, and the confidence data is adjusted depending on this determination.
摘要:
The present invention relates to a method of treating a disease or disorder in a patient comprising administering, to a patient in need of such treatment, an antibody which binds specifically to human angiopoietin-2 (ANG-2). The present invention also relates to a method for preventing metastasis in a patient suffering from primary cancer comprising administering, to a patient in need of such preventative treatment, an antibody which binds specifically to human angiopoietin-2 (ANG-2).
摘要:
The present invention relates to antibodies against human Angiopoietin 2 (anti-ANG-2 antibodies), methods for their production, pharmaceutical compositions containing said antibodies, and uses thereof.